Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines

Ann Oncol. 2012 Oct:23 Suppl 7:vii167-73. doi: 10.1093/annonc/mds294.

Authors

J A Pérez Fidalgo¹, L García Fabregat, A Cervantes, A Margulies, C Vidall, F Roila; ESMO Guidelines Working Group

Affiliation

¹ Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain.

PMID: 22997449
DOI: 10.1093/annonc/mds294

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Antidotes / administration & dosage
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Diagnosis, Differential
Extravasation of Diagnostic and Therapeutic Materials / diagnosis
Extravasation of Diagnostic and Therapeutic Materials / prevention & control*
Extravasation of Diagnostic and Therapeutic Materials / therapy
Humans
Neoplasms / drug therapy*
Risk Factors

Substances

Antidotes
Antineoplastic Agents